vs
Astrana Health, Inc.（ASTH）与PACS Group, Inc.（PACS）财务数据对比。点击上方公司名可切换其他公司
PACS Group, Inc.的季度营收约是Astrana Health, Inc.的1.4倍（$1.4B vs $950.5M），PACS Group, Inc.净利率更高（4.4% vs 0.7%，领先3.7%），Astrana Health, Inc.同比增速更快（42.9% vs 18.4%），过去两年Astrana Health, Inc.的营收复合增速更高（53.3% vs 20.5%）
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
ASTH vs PACS — 直观对比
营收规模更大
PACS
是对方的1.4倍
$950.5M
营收增速更快
ASTH
高出24.5%
18.4%
净利率更高
PACS
高出3.7%
0.7%
两年增速更快
ASTH
近两年复合增速
20.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $950.5M | $1.4B |
| 净利润 | $6.6M | $59.7M |
| 毛利率 | — | — |
| 营业利润率 | 1.9% | 7.0% |
| 净利率 | 0.7% | 4.4% |
| 营收同比 | 42.9% | 18.4% |
| 净利润同比 | 184.4% | 3022.5% |
| 每股收益（稀释后） | $0.12 | $0.42 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTHPACS
| Q4 25 | $950.5M | $1.4B | ||
| Q3 25 | $956.0M | $1.3B | ||
| Q2 25 | $654.8M | $1.3B | ||
| Q1 25 | $620.4M | $1.3B | ||
| Q4 24 | $665.2M | $1.1B | ||
| Q3 24 | $478.7M | $1.0B | ||
| Q2 24 | $486.3M | $981.4M | ||
| Q1 24 | $404.4M | $934.3M |
净利润ASTHPACS
| Q4 25 | $6.6M | $59.7M | ||
| Q3 25 | $373.0K | $52.4M | ||
| Q2 25 | $9.4M | $51.0M | ||
| Q1 25 | $6.7M | $28.5M | ||
| Q4 24 | $-7.8M | $1.9M | ||
| Q3 24 | $16.1M | $15.6M | ||
| Q2 24 | $19.2M | $-10.9M | ||
| Q1 24 | $14.8M | $49.1M |
毛利率ASTHPACS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 17.1% | ||
| Q2 24 | — | 22.3% | ||
| Q1 24 | — | 21.2% |
营业利润率ASTHPACS
| Q4 25 | 1.9% | 7.0% | ||
| Q3 25 | 2.0% | 6.4% | ||
| Q2 25 | 3.1% | 6.2% | ||
| Q1 25 | 3.3% | 3.8% | ||
| Q4 24 | 0.1% | 1.7% | ||
| Q3 24 | 5.9% | 2.2% | ||
| Q2 24 | 6.2% | 0.1% | ||
| Q1 24 | 7.5% | 8.6% |
净利率ASTHPACS
| Q4 25 | 0.7% | 4.4% | ||
| Q3 25 | 0.0% | 3.9% | ||
| Q2 25 | 1.4% | 3.9% | ||
| Q1 25 | 1.1% | 2.2% | ||
| Q4 24 | -1.2% | 0.2% | ||
| Q3 24 | 3.4% | 1.5% | ||
| Q2 24 | 3.9% | -1.1% | ||
| Q1 24 | 3.7% | 5.3% |
每股收益（稀释后）ASTHPACS
| Q4 25 | $0.12 | $0.42 | ||
| Q3 25 | $0.01 | $0.32 | ||
| Q2 25 | $0.19 | $0.31 | ||
| Q1 25 | $0.14 | $0.17 | ||
| Q4 24 | $-0.14 | $-0.03 | ||
| Q3 24 | $0.33 | $0.10 | ||
| Q2 24 | $0.40 | $-0.07 | ||
| Q1 24 | $0.31 | $0.38 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $197.0M |
| 总债务越低越好 | — | $353.2M |
| 股东权益账面价值 | $779.3M | $946.8M |
| 总资产 | $2.2B | $5.6B |
| 负债/权益比越低杠杆越低 | — | 0.37× |
8季度趋势，按日历期对齐
现金及短期投资ASTHPACS
| Q4 25 | $429.5M | $197.0M | ||
| Q3 25 | $463.4M | $355.7M | ||
| Q2 25 | $342.1M | $294.2M | ||
| Q1 25 | $260.9M | $287.5M | ||
| Q4 24 | $290.8M | $157.7M | ||
| Q3 24 | $350.3M | $49.5M | ||
| Q2 24 | $327.7M | $73.4M | ||
| Q1 24 | $337.3M | $81.2M |
总债务ASTHPACS
| Q4 25 | — | $353.2M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $411.9M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ASTHPACS
| Q4 25 | $779.3M | $946.8M | ||
| Q3 25 | $775.5M | $871.3M | ||
| Q2 25 | $765.5M | $806.8M | ||
| Q1 25 | $745.4M | $750.2M | ||
| Q4 24 | $712.7M | $709.6M | ||
| Q3 24 | $704.6M | $660.0M | ||
| Q2 24 | $678.9M | $572.1M | ||
| Q1 24 | $653.5M | $128.0M |
总资产ASTHPACS
| Q4 25 | $2.2B | $5.6B | ||
| Q3 25 | $2.2B | $5.6B | ||
| Q2 25 | $1.4B | $5.5B | ||
| Q1 25 | $1.3B | $5.5B | ||
| Q4 24 | $1.4B | $5.2B | ||
| Q3 24 | $1.3B | $4.5B | ||
| Q2 24 | $1.3B | $3.9B | ||
| Q1 24 | $1.2B | $3.9B |
负债/权益比ASTHPACS
| Q4 25 | — | 0.37× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.58× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $-3.4M |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | — |
| 自由现金流率自由现金流/营收 | -0.6% | — |
| 资本支出强度资本支出/营收 | 0.3% | — |
| 现金转化率经营现金流/净利润 | -0.44× | -0.06× |
| 过去12个月自由现金流最近4个季度 | $104.5M | — |
8季度趋势，按日历期对齐
经营现金流ASTHPACS
| Q4 25 | $-2.9M | $-3.4M | ||
| Q3 25 | $10.0M | $204.8M | ||
| Q2 25 | $90.9M | $52.6M | ||
| Q1 25 | $16.6M | $150.2M | ||
| Q4 24 | $-10.9M | $64.6M | ||
| Q3 24 | $34.0M | $209.2M | ||
| Q2 24 | $23.2M | $34.8M | ||
| Q1 24 | $6.0M | $58.8M |
自由现金流ASTHPACS
| Q4 25 | $-6.0M | — | ||
| Q3 25 | $7.4M | — | ||
| Q2 25 | $89.5M | — | ||
| Q1 25 | $13.6M | — | ||
| Q4 24 | $-13.5M | — | ||
| Q3 24 | $31.7M | — | ||
| Q2 24 | $20.4M | — | ||
| Q1 24 | $5.6M | — |
自由现金流率ASTHPACS
| Q4 25 | -0.6% | — | ||
| Q3 25 | 0.8% | — | ||
| Q2 25 | 13.7% | — | ||
| Q1 25 | 2.2% | — | ||
| Q4 24 | -2.0% | — | ||
| Q3 24 | 6.6% | — | ||
| Q2 24 | 4.2% | — | ||
| Q1 24 | 1.4% | — |
资本支出强度ASTHPACS
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.3% | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 0.4% | — | ||
| Q3 24 | 0.5% | — | ||
| Q2 24 | 0.6% | — | ||
| Q1 24 | 0.1% | — |
现金转化率ASTHPACS
| Q4 25 | -0.44× | -0.06× | ||
| Q3 25 | 26.69× | 3.91× | ||
| Q2 25 | 9.65× | 1.03× | ||
| Q1 25 | 2.48× | 5.28× | ||
| Q4 24 | — | 33.78× | ||
| Q3 24 | 2.11× | 13.39× | ||
| Q2 24 | 1.21× | — | ||
| Q1 24 | 0.40× | 1.20× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
PACS
暂无分部数据
